Ten years of biosimilars in Europe: development and evolution of the regulatory pathways

This paper was originally published by Martin Schiestl, Markus Zabransky, and Fritz Sörgel in Drug Des Devel Ther. 2017; 11: 1509–1515 under a Creative Commons Attribution – Non Commercial (unported, v3.0) License. Abstract…
The post Ten years of biosi…


Make better decisions with advanced biopharmaceutical business intelligence

What can we build for you? Do you have special business intelligence needs? Let us apply our industry expertise and the strength of the DrugPatentWatch platform to develop a solution…
The post Make better decisions with advanced biopharmaceutical busin…


Driving Innovation: Drug Patents vs. Prizes

Joseph E Stiglitz, American economist and professor at Columbia University, states that prizes should be favored over patents to reward and stimulate innovation. The uniqueness of the patent system referred…
The post Driving Innovation: Drug Patents vs…


Drug Patent Expirations for the Week of July 29, 2018

SPIRIVA (tiotropium bromide) Boehringer ingelheim Patent: RE39820 Expiration: Jul 30, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]
The post…


New patent expiration for Gilead drug LETAIRIS

Annual Drug Patent Expirations for LETAIRIS Letairis is a drug marketed by Gilead and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Gilead drug LETAIRIS appeared first o…


New patent expiration for Boehringer Ingelheim drug GILOTRIF

Annual Drug Patent Expirations for GILOTRIF Gilotrif is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Boehringer Ingelheim drug GILOTRIF…


New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…
The post New tentative approval for Watson Labs drug dienoge…


Injectable dosed drug patent expirations by year

This chart shows the patent expirations for injectable dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Injectable dosed drug patent expirations by year appeared first on DrugPate…


New patent lawsuit: Turlock Irrigation District v. Novartis Pharmaceuticals Corporation – Drug patent: 6,294,197

A new lawsuit citing drug patent 6,294,197 has been filed. The small molecule drugs covered by this patent are DIOVAN, DIOVAN HCT, EXFORGE, and EXFORGE HCT. See more details at…
The post New patent lawsuit: Turlock Irrigation District v. Novartis Pharm…


New patent lawsuit: Turlock Irrigation District v. Novartis Pharmaceuticals Corporation – Drug patent: 6,395,728

A new lawsuit citing drug patent 6,395,728 has been filed. The small molecule drug covered by this patent is EXFORGE. See more details at Turlock Irrigation District v. Novartis Pharmaceuticals…
The post New patent lawsuit: Turlock Irrigation District …


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: